The Influence of Substance Abuse on Inhibition Capacities and Risky Decision in a Group of Outpatient Schizophrenia Patients

References

• Adan, A., Capella, M. D. M., Prat, G., Forero, D. A., López-Vera, S., & Navarro, J. F. (2017). Executive functioning in men with schizophrenia and substance use disorders influence of lifetime suicide attempts. PLoS One, 12(1), e0169943. https://doi.org/10.1371/journal.pone.0169943
   PubMed Web of Science ®Google Scholar
• Addington, J., & Addington, D. (1997). Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatry & Neuroscience, 22(2), 99–104.
   PubMed Web of Science ®Google Scholar
• Badcock, J. C., Michie, P. T., Johnson, L., & Combrinck, J. (2002). Acts of control in schizophrenia: dissociating the components of inhibition. Psychological Medicine, 32(2), 287–297. https://doi.org/10.1017/S0033291701005128
   PubMed Web of Science ®Google Scholar
• Bari, A., & Robbins, T. W. (2013). Inhibition and impulsivity: Behavioral and neural basis of response control. Progress in Neurobiology, 108, 44–79. https://doi.org/10.1016/j.pneurobio.2013.06.005
   PubMed Web of Science ®Google Scholar
• Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, S. W., & Nathan, P. E. (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39(4), 376–389. https://doi.org/10.1016/S0028-3932(00)00136-6
   PubMed Web of Science ®Google Scholar
• D'Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry, 57(6), 594–608. https://doi.org/10.1016/j.biopsych.2004.12.006
   PubMed Web of Science ®Google Scholar
• Enticott, P. G., Ogloff, J. R. P., & Bradshaw, J. L. (2008). Response inhibition and impulsivity in schizophrenia. Psychiatry Research, 157(1–3), 251–254. https://doi.org/10.1016/j.psychres.2007.04.007
   PubMed Web of Science ®Google Scholar
• Ernst, M., & Paulus, M. P. (2005). Neurobiology of decision making: A selective review from a neurocognitive and clinical perspective. Biological Psychiatry, 58(8), 597–604. https://doi.org/10.1016/j.biopsych.2005.06.004
   PubMed Web of Science ®Google Scholar
• Florentin, S., & Raskin, S. (2017). Co-occuring schizophrenia and substance use disorder: Etiological Theories and challenges in Israel. Harefuah, 156(11), 715–719.
   PubMedGoogle Scholar
• Fridberg, D. J., Queller, S., Ahn, W.-Y., Kim, W., Bishara, A. J., Busemeyer, J. R., Porrino, L., & Stout, J. C. (2010). Cognitive mechanisms underlying risky decision-making in chronic cannabis users. Journal of Mathematical Psychology, 54(1), 28–38. https://doi.org/10.1016/j.jmp.2009.10.002
   PubMed Web of Science ®Google Scholar
• Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38(8), 1180–1187. https://doi.org/10.1016/S0028-3932(99)00158-X
   PubMed Web of Science ®Google Scholar
• Hoptman, M. J., Parker, E. M., Nair-Collins, S., Dias, E. C., Ross, M. E., DiCostanzo, J. N., Sehatpour, P., & Javitt, D. C. (2018). Sensory and cross-network contributions to response inhibition in patients with schizophrenia. NeuroImage, 18, 31–39. https://doi.org/10.1016/j.nicl.2018.01.001
   PubMed Web of Science ®Google Scholar
• Hutton, S. B., Murphy, F. C., Joyce, E. M., Rogers, R. D., Cuthbert, I., Barnes, T. R. E., McKenna, P. J., Sahakian, B. J., & Robbins, T. W. (2002). Decision making deficits in patients with first-episode and chronic schizophrenia. Schizophrenia Research, 55(3), 249–257. https://doi.org/10.1016/S0920-9964(01)00216-X
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. https://doi.org/10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Kertzman, S., Lidogoster, H., Aizer, A., Kotler, M., & Dannon, P. N. (2011). Risk-taking decisions in pathological gamblers is not a result of their impaired inhibition ability. Psychiatry Research, 188(1), 71–77. https://doi.org/10.1016/j.psychres.2011.02.021
   PubMed Web of Science ®Google Scholar
• Kertzman, S., Lowengrub, K., Aizer, A., Nahum, Z. B., Kotler, M., & Dannon, P. N. (2006). Stroop performance in pathological gamblers. Psychiatry Research, 142(1), 1–10. https://doi.org/10.1016/j.psychres.2005.07.027
   PubMed Web of Science ®Google Scholar
• Kertzman, S., Vainder, M., Vishne, T., Aizer, A., Kotler, M., & Dannon, P. N. (2010). Speed-accuracy tradeoff in decision-making performance among pathological gamblers. European Addiction Research, 16(1), 23–30. https://doi.org/10.1159/000253861
   PubMed Web of Science ®Google Scholar
• Koukouli, F., Rooy, M., Tziotis, D., Sailor, K. A., O'Neill, H. C., Levenga, J., Witte, M., Nilges, M., Changeux, J.-P., Hoeffer, C. A., Stitzel, J. A., Gutkin, B. S., DiGregorio, D. A., & Maskos, U. (2017). Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nature Medicine, 23(3), 347–354. https://doi.org/10.1038/nm.4274
   PubMed Web of Science ®Google Scholar
• Lee, D. (2013). Decision making: From neuroscience to psychiatry. Neuron, 78(2), 233–248. https://doi.org/10.1016/j.neuron.2013.04.008
   PubMed Web of Science ®Google Scholar
• Li, C. S., Huang, C., Yan, P., Bhagwagar, Z., Milivojevic, V., & Sinha, R. (2008). Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology, 33(8), 1798–1806. https://doi.org/10.1038/sj.npp.1301568
   PubMed Web of Science ®Google Scholar
• Løberg, E. M., & Hugdahl, K. (2009). Cannabis use and cognition in schizophrenia. Frontiers in Human Neuroscience, 3, 53–53. https://doi.org/10.3389/neuro.09.053.2009
   PubMed Web of Science ®Google Scholar
• Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K., & George, T. P. (2018). Neurobiological determinants of tobacco smoking in schizophrenia. Frontiers in Psychiatry, 9, 672. https://doi.org/10.3389/fpsyt.2018.00672
   PubMed Web of Science ®Google Scholar
• Marquez-Arrico, J., Río-Martínez, L., Navarro, J., Prat, G., Forero, D., & Adan, A. (2019). Coping strategies in male patients under treatment for substance use disorders and/or severe mental illness: Influence in clinical course at one-year follow-up. Journal of Clinical Medicine, 8(11), 1972. https://doi.org/10.3390/jcm8111972
   Web of Science ®Google Scholar
• Patton, J. H., Stanford, M. S., & Barratt, E. S. (1995). Factor structure of Barratt Impulsiveness Scale. Journal of Clinical Psychology, 51(6), 768–774. https://doi.org/10.1002/1097-4679(199511)51:6%3C768::AID-JCLP2270510607%3E3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Paulus, M. P. (2007). Decision-making dysfunctions in psychiatry-altered homeostatic processing? Science, 318(5850), 602–606. https://doi.org/10.1126/science.1142997
   PubMed Web of Science ®Google Scholar
• Pittaras, E. C., Faure, A., Leray, X., Moraitopoulou, E., Cressant, A., Rabat, A. A., Meunier, C., Fossier, P., & Granon, S. (2016). Neuronal nicotinic receptors are crucial for tuning of E/I balance in prelimbic cortex and for decision-making processes. Frontiers in Psychiatry, 7, 171. https://doi.org/10.3389/fpsyt.2016.00171
   PubMed Web of Science ®Google Scholar
• Rabin, R. A., Zakzanis, K. K., & George, T. P. (2011). The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis. Schizophrenia Research, 128(1–3), 111–116. https://doi.org/10.1016/j.schres.2011.02.017
   PubMed Web of Science ®Google Scholar
• Schnell, T., Koethe, D., Daumann, J., & Gouzoulis-Mayfrank, E. (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology, 205(1), 45–52. https://doi.org/10.1007/s00213-009-1512-9
   PubMed Web of Science ®Google Scholar
• Shurman, B., Horan, W. P., & Nuechterlein, K. H. (2005). Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophrenia Research, 72(2–3), 215–224. https://doi.org/10.1016/j.schres.2004.03.020
   PubMed Web of Science ®Google Scholar
• Tekin Uludag, Y., & Gulec, G. (2016). Prevalence of substance use in patients diagnosed with schizophrenia. Noro Psikiyatri Arsivi, 53(1), 4–11. https://doi.org/10.5152/npa.2015.8827
   PubMedGoogle Scholar